Glycine,N,N-bis[2-(2,6-dioxo-4-morpholinyl)ethyl]-

Product Information

Molecular Formula:
C14H19 N3 O8
Molecular Weight:
357.32
Description
Glycine, N,N-bis[2-(2,6-dioxo-4-morpholinyl)ethyl]- is a multifaceted compound of immense significance and finds extensive application within the realm of biomedicine. Prominently employed as a pivotal constituent in pharmaceutical formulations, this compound exhibits remarkable efficacy when combatting diverse afflictions encompassing cancer, diabetes, and neurological disorders. Its pharmacological potential propels it to the forefront of drug discovery and therapeutic interventions, solidifying its indispensable status within the realm of biomedicine.
Synonyms
N,N-BIS[2-(2,6-DIOXOMORPHOLINO)ETHYL]GLYCINE; DIETHYLENETRIAMINEPENTAACETIC ACID ANHYDRIDE; DIETHYLENETRIAMINEPENTAACETIC ANHYDRIDE; DIETHYLENETRIAMINEPENTAACETIC DIANHYDRIDE; DIETHYLENETRIAMINE-N,N,N',N'',N''-PENTAACETIC ACID ANHYDRIDE; DIETHYLENETRIAMINEPEN
IUPAC Name
2-[bis[2-(2,6-dioxomorpholin-4-yl)ethyl]amino]acetic acid
Canonical SMILES
C1C(=O)OC(=O)CN1CCN(CCN2CC(=O)OC(=O)C2)CC(=O)O
InChI
InChI=1S/C14H19N3O8/c18-10(19)5-15(1-3-16-6-11(20)24-12(21)7-16)2-4-17-8-13(22)25-14(23)9-17/h1-9H2,(H,18,19)
InChI Key
RAZLJUXJEOEYAM-UHFFFAOYSA-N
Boiling Point
656.2ºC at 760 mmHg
Melting Point
190-184ºC
Purity
>98.0%(T)
Density
1.46g/cm3
Appearance
white or cream white solid
Storage
−20°C

Safety Information

Hazards
H315:
Causes skin irritation.
H319:
Causes serious eye irritation.
Precautionary Statement
P264:
Wash thoroughly after handling.
P280:
Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352:
IF ON SKIN:
Wash with plenty of soap and water.
P332+P313:
If skin irritation occurs:
Get medical advice/attention.
P337+P313:
If eye irritation persists:
Get medical advice/attention.
P362+P364:
Take off contaminated clothing. [As modified by IV ATP].
And wash it before reuse. [Added by IV ATP].

Computed Properties

XLogP3
-3.3
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
11
Rotatable Bond Count
8
Exact Mass
357.11721457 g/mol
Monoisotopic Mass
357.11721457 g/mol
Topological Polar Surface Area
134Ų
Heavy Atom Count
25
Formal Charge
0
Complexity
504
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
CN-114042439-A Uranium-containing wastewater adsorbent and preparation method thereof 2021-12-15
CN-113209304-A Chelated calcium self-assembled nano particle and preparation method and application thereof 2021-05-19
CN-113234442-A Paramagnetic chiral graphene quantum dot and preparation method and application thereof 2021-05-11
CN-113509562-A Formulations comprising PD-L1 binding polypeptide compositions and methods of making the same 2021-04-22
CN-113057411-A Anti-skid shoe sole for women and preparation process of anti-skid shoe sole 2021-04-13
CN-112741837-A Brain-targeting nano-drug delivery system and preparation method thereof 2020-12-03
CN-112741837-B Brain-targeting nano-drug delivery system and preparation method thereof 2020-12-03
CN-112480151-A Novel fluorescent probe, preparation method thereof and application of novel fluorescent probe in detection of sulfadimidine in honey 2020-11-25
CN-112221539-A Catalyst for hydrosilylation reaction and preparation method and application thereof 2020-11-17
CN-112457797-A High-temperature-resistant cyanate ester conductive adhesive and preparation method thereof 2020-10-27

Literatures

PMID Publication Date Title Journal
22709587 2012-08-20 Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis Journal of controlled release : official journal of the Controlled Release Society
21922111 2011-12-01 Stability assessment of different chelating moieties used for elemental labeling of bio-molecules Metallomics : integrated biometal science
20592929 2010-07-01 Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model Korean journal of radiology
19919931 2009-12-01 Development of a radiolabeled beta-human chorionic gonadotropin Acta pharmaceutica (Zagreb, Croatia)
17785729 2007-09-01 Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer Journal of nuclear medicine : official publication, Society of Nuclear Medicine
16102904 2005-10-10 Synthesis and characterization of a novel DTPA polymerized hemoglobin based oxygen carrier Biochimica et biophysica acta
12433040 2002-11-01 Labeling of monoclonal antibodies with 153Sm for potential use in radioimmunotherapy Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
10628656 1999-12-01 Charge modification of plasma and milk proteins results in antiviral active compounds Journal of peptide science : an official publication of the European Peptide Society
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Inquiry Basket